Cheng, Weiqiu http://orcid.org/0000-0003-4001-8662
van der Meer, Dennis
Parker, Nadine
Hindley, Guy http://orcid.org/0000-0003-1666-4701
O’Connell, Kevin S.
Wang, Yunpeng
Shadrin, Alexey A.
Alnæs, Dag http://orcid.org/0000-0001-7361-5418
Bahrami, Shahram http://orcid.org/0000-0002-8179-2788
Lin, Aihua
Karadag, Naz
Holen, Børge
Fernandez-Cabello, Sara
Fan, Chun-Chieh http://orcid.org/0000-0001-9437-2128
Dale, Anders M. http://orcid.org/0000-0002-6126-2966
Djurovic, Srdjan http://orcid.org/0000-0002-8140-8061
Westlye, Lars T. http://orcid.org/0000-0001-8644-956X
Frei, Oleksandr
Smeland, Olav B. http://orcid.org/0000-0002-3761-5215
Andreassen, Ole A. http://orcid.org/0000-0002-4461-3568
Article History
Received: 14 March 2022
Revised: 10 August 2022
Accepted: 12 August 2022
First Online: 13 September 2022
Competing interests
: Dr. Andreassen reported grants from Stiftelsen Kristian Gerhard Jebsen, South-East Regional Health Authority, Research Council of Norway, and European Union’s Horizon 2020 during the conduct of the study; personal fees from HealthLytix (stock options), Lundbeck (speaker’s honorarium), and Sunovion (speaker’s honorarium) outside the submitted work; and had a pending patent for systems and methods for identifying polymorphisms. Dr. Dale reported grants from the National Institutes of Health outside the submitted work; had a patent for US7324842 licensed to Siemens Healthineers; is a founder of and holds equity in Cortechs Labs and serves on its scientific advisory board; is a member of the scientific advisory board of Human Longevity; a member of the scientific advisory board of Healthlytix; and receives funding through a research agreement with GE Healthcare. No other disclosures were reported.